Holen Sie sich die Stockscreener-App
0.00
100.00%
-2.0301
Schlusskurs vom Vortag:
$2.0301
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$35.38M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Firmenname
Mural Oncology Plc
Sektor
Branche
Telefon
353 1 905 8020
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Vergleichen Sie MURA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
0.00 | 35.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-04 | Eingeleitet | Morgan Stanley | Overweight |
Mural Oncology Plc Aktie (MURA) Neueste Nachrichten
Xoma Navigates Clinical Setback with Strategic Acquisition - AD HOC NEWS
Mural Oncology shareholders approve acquisition by XRA 5 Corp. - MSN
Xoma Royalty Expands Portfolio Through Mural Oncology Acquisition - AD HOC NEWS
Mural Oncology Announces Sanction of the Scheme by the High Court - 富途牛牛
XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share - Investing.com Nigeria
XOMA Royalty completes acquisition of Mural Oncology By Investing.com - Investing.com Nigeria
Xoma Completes Acquisition of Mural Oncology - TipRanks
Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition - Research Tree
Xoma Royalty announces closing of transaction to acquire Mural Oncology plc - marketscreener.com
XOMA Royalty Corporation Completes Acquisition of Mural Oncology plc Under Irish High Court Sanctioned Scheme - Quiver Quantitative
Mural Oncology Plc Completes Acquisition by XRA 5 Corp. - TipRanks
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - Yahoo Finance
XOMA Royalty completes acquisition of Mural Oncology - Investing.com India
Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) scheme with XOMA unit effective as Nasdaq listing ends - Stock Titan
Mural Oncology plc(NasdaqGM: MURA) dropped from S&P TMI Index - marketscreener.com
Mural Oncology plc (MURA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mural Oncology plc(NasdaqGM: MURA) dropped from NASDAQ Composite Index - marketscreener.com
REGCitadel Group Mural Oncology PLCForm 8.3Mural Oncology plc - TradingView — Track All Markets
XOMA Royalty Corporation completed the acquisition of Mural Oncology plc from group of shareholders. - marketscreener.com
Irish court approves XOMA Royalty’s acquisition of Mural Oncology - Investing.com India
Irish court approves XOMA Royalty’s acquisition of Mural Oncology By Investing.com - Investing.com Australia
Mural Oncology plc Announces Court Approval of Scheme for Acquisition by XOMA Royalty Corporation's Subsidiary - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) wins Irish court nod for XOMA deal, Nasdaq trading expected to end Dec. 4 - Stock Titan
Mural Oncology (MURA) Stock Analysis Report | Financials & Insights - Benzinga
Will Mural Oncology plc stock benefit from automationJuly 2025 Spike Watch & Weekly Watchlist of Top Performers - BỘ NỘI VỤ
Will Mural Oncology plc stock outperform value stocksJuly 2025 Gainers & AI Driven Stock Movement Reports - moha.gov.vn
Irish takeover panel lists three companies in offer periods By Investing.com - Investing.com Nigeria
Mural Oncology Shareholders To Receive $2.035 Cash Per Share In XOMA Royalty Acquisition - Nasdaq
Can Mural Oncology plc stock sustain revenue growth2025 Biggest Moves & Safe Entry Zone Identification - moha.gov.vn
Citadel Group discloses 1.39% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.39% stake in Mural Oncology - Investing.com India
XOMA Royalty to acquire Mural Oncology for $2.035 per share By Investing.com - Investing.com Nigeria
Mural Oncology Reports Final Consideration Payable on Closing of Acquisition by Xoma - marketscreener.com
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - The Globe and Mail
Form 8.3The Vanguard Group, Inc.: Mural Oncology plc - marketscreener.com
XOMA Royalty to acquire Mural Oncology for $2.035 per share - Investing.com
Mural Oncology plc Announces Final Determination of Additional Price Per Share in Acquisition by XOMA Royalty Corporation - Quiver Quantitative
Mural Oncology (Nasdaq: MURA) to Be Acquired by XOMA Royalty for $2.035 Cash - Stock Titan
Citadel Group discloses 1.38% stake in Mural Oncology - Investing.com India
Citadel Group discloses 1.38% stake in Mural Oncology By Investing.com - Investing.com South Africa
Finanzdaten der Mural Oncology Plc-Aktie (MURA)
Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Mural Oncology Plc-Aktie (MURA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Goodman Vicki L | Chief Medical Officer |
Nov 10 '25 |
Sale |
2.08 |
5,036 |
10,475 |
84,727 |
0.18%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):